User login
- /content/deucravacitinib-yields-higher-minimal-disease-activity-response-placebo-psa
- /rheumatology/article/271705/psoriatic-arthritis/deucravacitinib-yields-higher-minimal-disease-activity-response-placebo-psa-0
- /rheumatology/article/271705/psoriatic-arthritis/deucravacitinib-yields-higher-minimal-disease-activity-response-placebo-psa